Kalayoglu Murat 13D/13G Filings for Cartesian Therapeutics, Inc. (RNAC)

Kalayoglu Murat 13D and 13G filings for Cartesian Therapeutics, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
Type Company
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev Report View
2024-10-15
4:30 pm
Purchase
2024-10-11 13D Cartesian Therapeutics, Inc.
RNAC
Kalayoglu Murat 5,058,026
19.900%
1,519,640increase
(+42.95%)
Filing
2024-04-10
4:29 pm
Purchase
2024-04-08 13D Cartesian Therapeutics, Inc.
RNAC
Kalayoglu Murat 3,538,386
19.900%
2,226,904increase
(+169.80%)
Filing
2023-11-22
4:38 pm
Purchase
2023-11-13 13D Cartesian Therapeutics, Inc.
RNAC
Kalayoglu Murat 1,311,482
19.900%
1,311,482increase
(New Position)
Filing